Oric Pharmaceuticals Inc.
ORIC
NGS
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
3.25
USD
0.08
(2.52%)
Optionable: Yes Market Cap: 125 M 90-day average vol: 136,563
Previous close: 3.17 Open: 3.25 Bid: 4.6 Ask: 4.6
52 week range
2.62 23.20
Last updated: Thursday 29th September 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 0.00 |
Price per Book TTM ($) | 0.59 |
PE Ratio (TTM) | -1.60 |
Book Value per Share ($) | 5.99 |
5 Year PE Range | -9.1 , -7.7 |
Returns
7 Day Return | -7.93% | |
1 Month Return | -14.70% | |
3 Month Return | -27.46% | |
1 Year Return | -85.66% | |
3 Year Return | -87.39% | |
5 Year Return | -87.39% | |
YTD Return | -77.89% |
Risk
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 37.13 |
14 Day SMA ($) | 3.39 |
14 Day EMA ($) | 3.41 |
Money Flow Index | 43.40 |
Average True Range | 0.29 |
50 Day SMA ($) | 3.91 |
200 Day SMA ($) | 6.32 |
ADX | 21.46 |
MACD | -0.19 |
Growth
Free Cash Flow QoQ Growth | -21.32% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | -13.56% |
Revenue QoQ Growth | 0.00% |
EPS YoY Growth | 0.00% |
Profitability
News
Financials
ORIC Income Statement
Annual
| Invalid date | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | |
| Cost of sales | -903000 | -1 M | -1 M | -2 M | |
| Gross operating profit | 0 | 0 | 0 | 0 | |
| Selling Gen & administrative expense | 3 M | 6 M | 13 M | 22 M | |
| Research & development expense | 19 M | 23 M | 36 M | 57 M | |
| Operating income | -22 M | -29 M | -49 M | -79 M | |
| floaterest income | 0 | 0 | 0 | 0 | |
| floaterest expense | 0 | 0 | 0 | 0 | |
| Other income net | 233000 | 289000 | -25 M | 15000 | |
| Pre-tax Income (EBT) | -21 M | -27 M | -74 M | -79 M | |
| Income taxes | 0 | 0 | 0 | 0 | |
| Net income from total operations | -21 M | -27 M | -74 M | -79 M | |
| Minority floaterest | 0 | 0 | 0 | 0 | |
| Total net income | -21 M | -27 M | -74 M | -79 M | |
| Preferred dividends | N/A | N/A | N/A | N/A | |
| Net income available for common | -21 M | -27 M | -74 M | -79 M | |
| Depreciation | 903000 | 1 M | 1 M | 2 M | |
| Amortization | 0 | 0 | 0 | 0 | |
| Operating income before depreciation (EBITDA) | -21 M | -28 M | -48 M | -78 M | |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | |
| Basic EPS total | -1.12 | -1.4 | -3.36 | -2.07 | |
| Diluted EPS total | -1.12 | -1.4 | -3.36 | -2.07 |
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONSGet started today